Search

everythinglearnresearchcommunity

for

Search:↓

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

CYB5R1 and IL1A genes may be linked to different types of acne scars.

Upadacitinib effectively treats severe alopecia areata and is safe.

Baricitinib is effective and safe for treating severe alopecia areata.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib is effective and safe for treating severe alopecia areata.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Skin tags in severely obese people may indicate higher blood pressure and diabetes risk.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Juvéderm Ultra Plus is safe and effective for treating severe nasolabial folds in Chinese subjects.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.